Shobana Balasingam

816 total citations
19 papers, 559 citations indexed

About

Shobana Balasingam is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Shobana Balasingam has authored 19 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 7 papers in Epidemiology and 6 papers in Immunology. Recurrent topics in Shobana Balasingam's work include Influenza Virus Research Studies (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Tuberculosis Research and Epidemiology (3 papers). Shobana Balasingam is often cited by papers focused on Influenza Virus Research Studies (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Tuberculosis Research and Epidemiology (3 papers). Shobana Balasingam collaborates with scholars based in United Kingdom, United States and Singapore. Shobana Balasingam's co-authors include Rob Lambkin‐Williams, John Oxford, Patricia Novelli, Anita Mann, Annelies Wilder‐Smith, Alex Mann, Sarit Samira, Nigel J. Dimmock, Alex Mann and Anthony C. Marriott and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Infectious Diseases.

In The Last Decade

Shobana Balasingam

18 papers receiving 537 citations

Peers

Countries citing papers authored by Shobana Balasingam

Since Specialization

Citations

This map shows the geographic impact of Shobana Balasingam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shobana Balasingam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shobana Balasingam more than expected).

Fields of papers citing papers by Shobana Balasingam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shobana Balasingam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shobana Balasingam. The network helps show where Shobana Balasingam may publish in the future.

Co-authorship network of co-authors of Shobana Balasingam

This figure shows the co-authorship network connecting the top 25 collaborators of Shobana Balasingam. A scholar is included among the top collaborators of Shobana Balasingam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shobana Balasingam. Shobana Balasingam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Ethical approval for controlled human infectious model clinical trial protocols – A workshop report 2024 ·Biologicals ·Euzebiusz Jamrozik, Katherine Littler, (unknown), (unknown), (unknown), Ole F. Olesen, (unknown), Shobana Balasingam, Pieter Neels	0
2	Review of Current Tuberculosis Human Infection Studies for Use in Accelerating Tuberculosis Vaccine Development: A Meeting Report 2024 ·The Journal of Infectious Diseases ·Shobana Balasingam, Keertan Dheda, Sarah M. Fortune, Stephen B. Gordon, Daniel F. Hoft, James G. Kublin, Colleen N. Loynachan, Helen McShane, Ben Morton, (unknown), (unknown), Brian D. Robertson, Lewis K. Schrager, Charlotte Weller	5
3	Practical considerations for a TB controlled human infection model (TB-CHIM); the case for TB-CHIM in Africa, a systematic review of the literature and report of 2 workshop discussions in UK and Malawi 2023 ·SHILAP Revista de lepidopterología ·Stephen B. Gordon, (unknown), (unknown), Phoebe Hazenberg, (unknown), Daniela M. Ferreira, JoAnne L. Flynn, Sarah M. Fortune, Shobana Balasingam, Giancarlo A. Biagini, Helen McShane, Henry C. Mwandumba, Kondwani Jambo, Keertan Dheda, (unknown), Brian D. Robertson, Naomi F. Walker, Ben Morton, (unknown)	3
4	Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities—workshop report 2023 ·npj Vaccines ·Jane M. Knisely, (unknown), Rebecca Mandt, (unknown), Shobana Balasingam, (unknown), Ursula J. Buchholz, M. Patricia D’Souza, Jennifer L. Gordon, (unknown), Tung Thanh Le, Wolfgang W. Leitner, Robert A. Seder, Alkis Togias, Stig Tollefsen, David W. Vaughn, Daniel Wolfe, Kimberly L. Taylor, Anthony S. Fauci	56
5	Practical considerations for a TB controlled human infection model (TB-CHIM); the case for TB-CHIM in Africa, a systematic review of the literature and report of 2 workshop discussions in UK and Malawi 2023 ·SHILAP Revista de lepidopterología ·Stephen B. Gordon, (unknown), (unknown), Phoebe Hazenberg, (unknown), Daniela M. Ferreira, JoAnne L. Flynn, Sarah M. Fortune, Shobana Balasingam, Giancarlo A. Biagini, Helen McShane, Henry C. Mwandumba, Kondwani Jambo, (unknown), (unknown), Brian D. Robertson, Naomi F. Walker, Ben Morton, (unknown)	2
6	A Brief History of Human Challenge Studies (1900–2021) Emphasising the Virology, Regulatory and Ethical Requirements, Raison D’etre, Ethnography, Selection of Volunteers and Unit Design 2022 ·Current topics in microbiology and immunology ·John Oxford, Anthony Catchpole, Anita Mann, (unknown), Nicolas Noulin, Débora Gil, (unknown), Anthony Gilbert, Shobana Balasingam	1
7	Randomized controlled trials for influenza drugs and vaccines: a review of controlled human infection studies 2016 ·International Journal of Infectious Diseases ·Shobana Balasingam, Annelies Wilder‐Smith	31
8	Low antibody titers 5 years after vaccination with the CYD-TDV dengue vaccine in both pre-immune and naïve vaccinees 2016 ·Human Vaccines & Immunotherapeutics ·Sumathy Velumani, Ying Xiu Toh, Shobana Balasingam, Sophia Archuleta, Yee‐Sin Leo, Victor C. Gan, Tun-Linn Thein, Annelies Wilder‐Smith, Katja Fink	18
9	The potential for a controlled human infection platform in Singapore 2014 ·Singapore Medical Journal ·Shobana Balasingam, Peter Horby, Annelies Wilder‐Smith	10
10	A new intranasal influenza vaccine based on a novel polycationic lipid-ceramide carbamoyl-spermine (CCS). II. Studies in mice and ferrets and mechanism of adjuvanticity 2011 ·Vaccine ·(unknown), Aviva Joseph, (unknown), Sarit Samira, (unknown), Hagit Eliyahu, (unknown), Shobana Balasingam, Alex Mann, Rob Lambkin‐Williams	38
11	Immunogenicity, protective efficacy and mechanism of novel CCS adjuvanted influenza vaccine 2010 ·Vaccine ·(unknown), Sarit Samira, (unknown), Shobana Balasingam, Alex Mann, Rob Lambkin‐Williams, Jack Spira, (unknown), R. John Ellis, Yechezkel Barenholz	30
12	Inhaled Cationic Airway Lining Modulator (iCALM) Therapy, A Novel Aerosol Treatment For Respiratory Infections Reduces Clinical Symptoms And Transmission Of Influenza A Infection. 2010 ·David L. Hava, L.C. Griel, Wesley DeHaan, Cédric Hubeau, Jennifer Kenyon, Michael M. Lipp, Rob Lambkin‐Williams, Shobana Balasingam, Robert W. Clarke	1
13	Preclinical Evaluation of a Replication-Deficient Intranasal ΔNS1 H5N1 Influenza Vaccine 2009 ·PLoS ONE ·Julia Romanova, Brigitte M. Krenn, Markus Wolschek, Boris Ferko, (unknown), (unknown), Anna-Polina Shurygina, Sabine Nakowitsch, Tanja Ruthsatz, (unknown), Ulrich König, Michael Bergmann, Monika Sachet, Shobana Balasingam, Alex Mann, John Oxford, (unknown), О. И. Киселев, Thomas Muster, Andrej Egorov	57
14	Interfering vaccine (defective interfering influenza A virus) protects ferrets from influenza, and allows them to develop solid immunity to reinfection 2006 ·Vaccine ·Alex Mann, Anthony C. Marriott, Shobana Balasingam, Rob Lambkin‐Williams, John Oxford, Nigel J. Dimmock	40
15	A Throat Lozenge Containing Amyl Meta Cresol and Dichlorobenzyl Alcohol Has a Direct Virucidal Effect on Respiratory Syncytial Virus, Influenza a and SARS-CoV 2005 ·Antiviral chemistry & chemotherapy ·John Oxford, Rob Lambkin‐Williams, Iain Gibb, Shobana Balasingam, (unknown), Andrew Catchpole	27
16	New Antiviral Drugs, Vaccines and Classic Public Health Interventions against SARS Coronavirus 2005 ·Antiviral chemistry & chemotherapy ·John Oxford, Shobana Balasingam, (unknown), Andrew Catchpole, Rob Lambkin‐Williams	9
17	Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors 2003 ·Clinical Microbiology and Infection ·John Oxford, (unknown), Shobana Balasingam, Anita Mann, Patricia Novelli, Rob Lambkin‐Williams	210
18	Advance directives: barriers to completion. 1998 ·PubMed ·(unknown), (unknown), Shobana Balasingam, (unknown), (unknown)	12
19	Early clinical manifestations in filariasis due to Brugia malayi: observations on experimental infections in man. 1972 ·Southeast Asian Journal of Tropical Medicine and Public Health ·T. J. Dondero, (unknown), Shobana Balasingam	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact